Art

J-GLOBAL ID：202002214953945549   Reference number：20A1408225

The optimization in busulfan-based conditioning on hematopoietic stem cell transplantation for children

小児の造血幹細胞移植前処置におけるブスルファン投与法の最適化

Author (1)： OSUMI TOMOO (国立成育医療研究セ 小児がんセ)
Material： 臨床薬理の進歩  (Recent Advances in Clinical Pharmacology)
Issue： 41  Page： 125-132  Publication year： Jun. 20, 2020 
JST Material Number： Y0720A  ISSN： 0914-4366  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *hematopoietic stem cell transplantation ,...
Semi thesaurus term： reduced intensity stem cell transplantation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1408225&from=J-GLOBAL&jstjournalNo=Y0720A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (2)： Busulfan ,  Levetiracetam

Reference (12)：

• Ishida H, Kato M, Kudo K, Taga T, Tomizawa D, Miyamura T, et al. Comparison of outcomes for pediatric patients with acute myeloid leukemia in remission and undergoing allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens based on either intravenous busulfan or total body irradiation: A report from the Japanese society for hematopoietic cell transplantation. Biol blood marrow transplant 2015; 21: 2141-7.
• Kato M, Ishida H, Koh K, Inagaki J, Kato K, Goto H, et al. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan society for hematopoietic cell transplantation. Pediatr Blood Cancer 2015; 62: 1844-50.
• Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155-69.
• Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002; 100: 4344-50.
• Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014; 383: 436-48.

Terms in the title (6)： 小児 ,  造血幹細胞移植 ,  前処置 ,  ブスルファン ,  投与法 ,  最適化